151 related articles for article (PubMed ID: 16739375)
1. [The relationship between expression of Fhit and biological behaviors of hypopharyngeal carcinoma].
Wu H; Luan X; Zhou W; Pan X; Xu F; Lei D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(6):249-50. PubMed ID: 16739375
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma].
Yin DT; Lu XB; Dong MM; Qiu XG; Wang QZ
Ai Zheng; 2004 Nov; 23(11):1338-41. PubMed ID: 15522186
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical value of eukaryotic initiation factor 4E and matrix metalloproteinase-9 in supraglottic and hypopharyngeal carcinoma and metastasis lymph].
Sun S; Liu Q; Zhang A; He E
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Dec; 20(24):1116-9. PubMed ID: 17357517
[TBL] [Abstract][Full Text] [Related]
4. [Loss of fragile histidine triad expression and metastasis in breast cancer].
Zhao P; Li XY; Chen LZ
Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
[TBL] [Abstract][Full Text] [Related]
5. [The expression and role of VEGF-C and its receptor FLT-4 in laryngeal and hypopharyngeal squamous cell carcinoma metastasis].
Li L; Liu Q; Dong P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Sep; 19(18):845-9. PubMed ID: 16375119
[TBL] [Abstract][Full Text] [Related]
6. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
Yao CC; Lin CY; Hu MB
Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
[TBL] [Abstract][Full Text] [Related]
7. [Methylation of promoter and expression of FHIT gene in laryngeal squamous cell carcinoma].
Yin D; Dong M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(6):253-5, 258. PubMed ID: 16013507
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between the expression of fragile histidine (FHIT) and the development of vulvar carcinoma].
Chu YX; Zheng A; Xi MR; Zhang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):218-20. PubMed ID: 16608079
[TBL] [Abstract][Full Text] [Related]
9. Loss of fragile histidine triad expression in colorectal carcinoma.
Zhao P; Lu Y; Hu Y; Zhong M; Li Z; Li X
Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):124-7. PubMed ID: 12419158
[TBL] [Abstract][Full Text] [Related]
10. Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: a poor prognostic factor.
Krivak TC; McBroom JW; Seidman J; Venzon D; Crothers B; MacKoul PJ; Rose GS; Carlson JW; Birrer MJ
Cancer Res; 2001 Jun; 61(11):4382-5. PubMed ID: 11389064
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of fragile histidine triad in oral cancer and precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):584-6. PubMed ID: 15897145
[TBL] [Abstract][Full Text] [Related]
12. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P
Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological analysis of loss of fragile histidine triad expression in lung cancer].
Zhao P; Lv Y; Zhong M; Chen L
Zhongguo Fei Ai Za Zhi; 2002 Oct; 5(5):345-8. PubMed ID: 21329602
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer].
Zhu LQ; Diao LM; Chen DJ; Li HG; Liu X; Zou ZY; Li BY; Wang M; Liu MQ
Ai Zheng; 2003 Jun; 22(6):571-4. PubMed ID: 12948402
[TBL] [Abstract][Full Text] [Related]
15. [Fragile histidine triad protein expression and correlation with apoptosis in rectal carcinoma].
Cao J; Xia J; Wang H; DU H; Li WL
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar; 10(2):177-81. PubMed ID: 17380463
[TBL] [Abstract][Full Text] [Related]
16. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers.
Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101
[TBL] [Abstract][Full Text] [Related]
17. FHIT expression and hypermethylation in esophageal squamous cell carcinoma.
Noguchi T; Takeno S; Kimura Y; Uchida Y; Daa T; Yokoyama S; Gabbert HE; Mueller W
Int J Mol Med; 2003 Apr; 11(4):441-7. PubMed ID: 12632095
[TBL] [Abstract][Full Text] [Related]
18. Fhit, E-cadherin, p53, and activation-induced cytidine deaminase expression in endoscopically resected early stage esophageal squamous neoplasia.
Hayashi A; Yashima K; Takeda Y; Sasaki S; Kawaguchi K; Harada K; Murawaki Y; Ito H
J Gastroenterol Hepatol; 2012 Nov; 27(11):1752-8. PubMed ID: 22742976
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
[TBL] [Abstract][Full Text] [Related]
20. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]